Europe Adalimumab Market Report 2016

November 2016 | 100 pages | ID: E8F13E4D989EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Adalimumab

Revenue, means the sales value of Adalimumab

This report studies sales (consumption) of Adalimumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Janssen Biotech
• GlaxoSmithKline
• Sanofi
• MedImmune
• UCB
• Novartis
• Delenex Therapeutics
• Ablynx
• Sandoz
• Zydus Cadila

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Adalimumab in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Adalimumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Adalimumab Market Report 2016

1 ADALIMUMAB OVERVIEW

1.1 Product Overview and Scope of Adalimumab
1.2 Classification of Adalimumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Adalimumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Adalimumab Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Adalimumab (2011-2021)
  1.5.1 Europe Adalimumab Sales and Growth Rate (2011-2021)
  1.5.2 Europe Adalimumab Revenue and Growth Rate (2011-2021)

2 EUROPE ADALIMUMAB BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Adalimumab Market Competition by Manufacturers
  2.1.1 Europe Adalimumab Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Adalimumab Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Adalimumab (Volume and Value) by Type
  2.2.1 Europe Adalimumab Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Adalimumab Revenue and Market Share by Type (2011-2016)
2.3 Europe Adalimumab (Volume and Value) by Countries
  2.3.1 Europe Adalimumab Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Adalimumab Revenue and Market Share by Countries (2011-2016)
2.4 Europe Adalimumab (Volume) by Application

3 GERMANY ADALIMUMAB (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Adalimumab Sales and Value (2011-2016)
  3.1.1 Germany Adalimumab Sales and Growth Rate (2011-2016)
  3.1.2 Germany Adalimumab Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Adalimumab Sales Price Trend (2011-2016)
3.2 Germany Adalimumab Sales and Market Share by Manufacturers
3.3 Germany Adalimumab Sales and Market Share by Type
3.4 Germany Adalimumab Sales and Market Share by Application

4 FRANCE ADALIMUMAB (VOLUME, VALUE AND SALES PRICE)

4.1 France Adalimumab Sales and Value (2011-2016)
  4.1.1 France Adalimumab Sales and Growth Rate (2011-2016)
  4.1.2 France Adalimumab Revenue and Growth Rate (2011-2016)
  4.1.4 France Adalimumab Sales Price Trend (2011-2016)
4.2 France Adalimumab Sales and Market Share by Manufacturers
4.3 France Adalimumab Sales and Market Share by Type
4.4 France Adalimumab Sales and Market Share by Application

5 UK ADALIMUMAB (VOLUME, VALUE AND SALES PRICE)

5.1 UK Adalimumab Sales and Value (2011-2016)
  5.1.1 UK Adalimumab Sales and Growth Rate (2011-2016)
  5.1.2 UK Adalimumab Revenue and Growth Rate (2011-2016)
  5.1.5 UK Adalimumab Sales Price Trend (2011-2016)
5.2 UK Adalimumab Sales and Market Share by Manufacturers
5.3 UK Adalimumab Sales and Market Share by Type
5.4 UK Adalimumab Sales and Market Share by Application

6 RUSSIA ADALIMUMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Adalimumab Sales and Value (2011-2016)
  6.1.1 Russia Adalimumab Sales and Growth Rate (2011-2016)
  6.1.2 Russia Adalimumab Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Adalimumab Sales Price Trend (2011-2016)
6.2 Russia Adalimumab Sales and Market Share by Manufacturers
6.3 Russia Adalimumab Sales and Market Share by Type
6.4 Russia Adalimumab Sales and Market Share by Application

7 ITALY ADALIMUMAB (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Adalimumab Sales and Value (2011-2016)
  7.1.1 Italy Adalimumab Sales and Growth Rate (2011-2016)
  7.1.2 Italy Adalimumab Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Adalimumab Sales Price Trend (2011-2016)
7.2 Italy Adalimumab Sales and Market Share by Manufacturers
7.3 Italy Adalimumab Sales and Market Share by Type
7.4 Italy Adalimumab Sales and Market Share by Application

8 SPAIN ADALIMUMAB (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Adalimumab Sales and Value (2011-2016)
  8.1.1 Spain Adalimumab Sales and Growth Rate (2011-2016)
  8.1.2 Spain Adalimumab Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Adalimumab Sales Price Trend (2011-2016)
8.2 Spain Adalimumab Sales and Market Share by Manufacturers
8.3 Spain Adalimumab Sales and Market Share by Type
8.4 Spain Adalimumab Sales and Market Share by Application

9 BENELUX ADALIMUMAB (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Adalimumab Sales and Value (2011-2016)
  9.1.1 Benelux Adalimumab Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Adalimumab Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Adalimumab Sales Price Trend (2011-2016)
9.2 Benelux Adalimumab Sales and Market Share by Manufacturers
9.3 Benelux Adalimumab Sales and Market Share by Type
9.4 Benelux Adalimumab Sales and Market Share by Application

10 EUROPE ADALIMUMAB MANUFACTURERS ANALYSIS

10.1 Janssen Biotech
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Adalimumab Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Janssen Biotech Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Adalimumab Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 GlaxoSmithKline Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Sanofi
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Adalimumab Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Sanofi Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 MedImmune
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Adalimumab Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 MedImmune Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 UCB
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Adalimumab Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 UCB Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Novartis
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Adalimumab Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Novartis Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Delenex Therapeutics
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Adalimumab Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Delenex Therapeutics Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Ablynx
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Adalimumab Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Ablynx Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Sandoz
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Adalimumab Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Zydus Cadila
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Adalimumab Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Zydus Cadila Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 ADALIMUMAB MANUFACTURING COST ANALYSIS

11.1 Adalimumab Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Adalimumab

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Adalimumab Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Adalimumab Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ADALIMUMAB MARKET FORECAST (2016-2021)

14.1 Germany Adalimumab Sales Forecast (2016-2021)
14.2 France Adalimumab Sales Forecast (2016-2021)
14.3 UK Adalimumab Sales Forecast (2016-2021)
14.4 Russia Adalimumab Sales Forecast (2016-2021)
14.5 Italy Adalimumab Sales Forecast (2016-2021)
14.6 Spain Adalimumab Sales Forecast (2016-2021)
14.7 Benelux Adalimumab Sales Forecast (2016-2021)
14.8 Europe Adalimumab Sales Forecast by Type (2016-2021)
14.9 Europe Adalimumab Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Adalimumab
Table Classification of Adalimumab
Figure Europe Sales Market Share of Adalimumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Adalimumab
Figure Europe Sales Market Share of Adalimumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Adalimumab Revenue and Growth Rate (2011-2021)
Figure France Adalimumab Revenue and Growth Rate (2011-2021)
Figure UK Adalimumab Revenue and Growth Rate (2011-2021)
Figure Russia Adalimumab Revenue and Growth Rate (2011-2021)
Figure Italy Adalimumab Revenue and Growth Rate (2011-2021)
Figure Spain Adalimumab Revenue and Growth Rate (2011-2021)
Figure Benelux Adalimumab Revenue and Growth Rate (2011-2021)
Figure Europe Adalimumab Sales and Growth Rate (2011-2021)
Figure Europe Adalimumab Revenue and Growth Rate (2011-2021)
Table Europe Adalimumab Sales of Key Manufacturers (2015 and 2016)
Table Europe Adalimumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Adalimumab Sales Share by Manufacturers
Figure 2016 Adalimumab Sales Share by Manufacturers
Table Europe Adalimumab Revenue by Manufacturers (2015 and 2016)
Table Europe Adalimumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Adalimumab Revenue Share by Manufacturers
Table 2016 Europe Adalimumab Revenue Share by Manufacturers
Table Europe Adalimumab Sales and Market Share by Type (2011-2016)
Table Europe Adalimumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Adalimumab by Type (2011-2016)
Figure Europe Adalimumab Sales Growth Rate by Type (2011-2016)
Table Europe Adalimumab Revenue and Market Share by Type (2011-2016)
Table Europe Adalimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Adalimumab by Type (2011-2016)
Figure Europe Adalimumab Revenue Growth Rate by Type (2011-2016)
Table Europe Adalimumab Sales and Market Share by Countries (2011-2016)
Table Europe Adalimumab Sales Share by Countries (2011-2016)
Figure Sales Market Share of Adalimumab by Countries (2011-2016)
Table Europe Adalimumab Revenue and Market Share by Countries (2011-2016)
Table Europe Adalimumab Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Adalimumab by Countries (2011-2016)
Table Europe Adalimumab Sales and Market Share by Application (2011-2016)
Table Europe Adalimumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Adalimumab by Application (2011-2016)
Figure Germany Adalimumab Sales and Growth Rate (2011-2016)
Figure Germany Adalimumab Revenue and Growth Rate (2011-2016)
Figure Germany Adalimumab Sales Price Trend (2011-2016)
Table Germany Adalimumab Sales by Manufacturers (2015 and 2016)
Table Germany Adalimumab Market Share by Manufacturers (2015 and 2016)
Table Germany Adalimumab Sales by Type (2015 and 2016)
Table Germany Adalimumab Market Share by Type (2015 and 2016)
Table Germany Adalimumab Sales by Application (2015 and 2016)
Table Germany Adalimumab Market Share by Application (2015 and 2016)
Figure France Adalimumab Sales and Growth Rate (2011-2016)
Figure France Adalimumab Revenue and Growth Rate (2011-2016)
Figure France Adalimumab Sales Price Trend (2011-2016)
Table France Adalimumab Sales by Manufacturers (2015 and 2016)
Table France Adalimumab Market Share by Manufacturers (2015 and 2016)
Table France Adalimumab Sales by Type (2015 and 2016)
Table France Adalimumab Market Share by Type (2015 and 2016)
Table France Adalimumab Sales by Application (2015 and 2016)
Table France Adalimumab Market Share by Application (2015 and 2016)
Figure UK Adalimumab Sales and Growth Rate (2011-2016)
Figure UK Adalimumab Revenue and Growth Rate (2011-2016)
Figure UK Adalimumab Sales Price Trend (2011-2016)
Table UK Adalimumab Sales by Manufacturers (2015 and 2016)
Table UK Adalimumab Market Share by Manufacturers (2015 and 2016)
Table UK Adalimumab Sales by Type (2015 and 2016)
Table UK Adalimumab Market Share by Type (2015 and 2016)
Table UK Adalimumab Sales by Application (2015 and 2016)
Table UK Adalimumab Market Share by Application (2015 and 2016)
Figure Russia Adalimumab Sales and Growth Rate (2011-2016)
Figure Russia Adalimumab Revenue and Growth Rate (2011-2016)
Figure Russia Adalimumab Sales Price Trend (2011-2016)
Table Russia Adalimumab Sales by Manufacturers (2015 and 2016)
Table Russia Adalimumab Market Share by Manufacturers (2015 and 2016)
Table Russia Adalimumab Sales by Type (2015 and 2016)
Table Russia Adalimumab Market Share by Type (2015 and 2016)
Table Russia Adalimumab Sales by Application (2015 and 2016)
Table Russia Adalimumab Market Share by Application (2015 and 2016)
Figure Italy Adalimumab Sales and Growth Rate (2011-2016)
Figure Italy Adalimumab Revenue and Growth Rate (2011-2016)
Figure Italy Adalimumab Sales Price Trend (2011-2016)
Table Italy Adalimumab Sales by Manufacturers (2015 and 2016)
Table Italy Adalimumab Market Share by Manufacturers (2015 and 2016)
Table Italy Adalimumab Sales by Type (2015 and 2016)
Table Italy Adalimumab Market Share by Type (2015 and 2016)
Table Italy Adalimumab Sales by Application (2015 and 2016)
Table Italy Adalimumab Market Share by Application (2015 and 2016)
Figure Spain Adalimumab Sales and Growth Rate (2011-2016)
Figure Spain Adalimumab Revenue and Growth Rate (2011-2016)
Figure Spain Adalimumab Sales Price Trend (2011-2016)
Table Spain Adalimumab Sales by Manufacturers (2015 and 2016)
Table Spain Adalimumab Market Share by Manufacturers (2015 and 2016)
Table Spain Adalimumab Sales by Type (2015 and 2016)
Table Spain Adalimumab Market Share by Type (2015 and 2016)
Table Spain Adalimumab Sales by Application (2015 and 2016)
Table Spain Adalimumab Market Share by Application (2015 and 2016)
Figure Benelux Adalimumab Sales and Growth Rate (2011-2016)
Figure Benelux Adalimumab Revenue and Growth Rate (2011-2016)
Figure Benelux Adalimumab Sales Price Trend (2011-2016)
Table Benelux Adalimumab Sales by Manufacturers (2015 and 2016)
Table Benelux Adalimumab Market Share by Manufacturers (2015 and 2016)
Table Benelux Adalimumab Sales by Type (2015 and 2016)
Table Benelux Adalimumab Market Share by Type (2015 and 2016)
Table Benelux Adalimumab Sales by Application (2015 and 2016)
Table Benelux Adalimumab Market Share by Application (2015 and 2016)
Table Adalimumab Basic Information List
Table Janssen Biotech Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Janssen Biotech Adalimumab Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Adalimumab Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Adalimumab Sales Market Share (2011-2016)
Table MedImmune Basic Information List
Table MedImmune Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table MedImmune Adalimumab Sales Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB Adalimumab Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Adalimumab Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Adalimumab Sales Market Share (2011-2016)
Table Ablynx Basic Information List
Table Ablynx Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ablynx Adalimumab Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Adalimumab Sales Market Share (2011-2016)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila Adalimumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab
Figure Manufacturing Process Analysis of Adalimumab
Figure Adalimumab Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Major Manufacturers in 2015
Table Major Buyers of Adalimumab
Table Distributors/Traders List
Figure Germany Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure Germany Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Figure France Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure France Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Figure UK Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure UK Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure Russia Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure Italy Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure Spain Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Table Europe Adalimumab Sales Forecast by Type (2016-2021)
Table Europe Adalimumab Sales Forecast by Application (2016-2021)